PT Kimia Farma Tbk (IDX: KAEF)

Market Cap	4.01T
Revenue (ttm)	10.23T
Net Income (ttm)	-1,690.59B
Shares Out	5.57B
EPS (ttm)	-303.75
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,610,500
Open	725.00
Previous Close	720.00
Day's Range	725.00 - 765.00
52-Week Range	535.00 - 1,935.00
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About PT Kimia Farma Tbk

PT Kimia Farma Tbk engages in the manufacturing and sale of pharmaceutical products in Indonesia. It also provides generic, ethical, license and narcotic medicines, over the counter medicines, raw materials, medicines, medical devices, and cosmetic products, as well as rapid test diagnostic tools. In addition, the company is involved manufacturing and marketing of pharmaceutical raw materials and active pharmaceutical ingredients; health foods and effervescent tablets; quinine salt and related derivatives; and castor oil and edible oil. Further...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1817
• Employees: 11,461
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: KAEF

Financial Performance

In 2023, PT Kimia Farma Tbk's revenue was 9.97 trillion, an increase of 7.93% compared to the previous year's 9.23 trillion. Losses were -1,485.56 billion, 679.9% more than in 2022.